Skip to main content
. 2020 Nov 21;9(24):9419–9430. doi: 10.1002/cam4.3564

TABLE 1.

Correlation between patient‐ and physician‐reported outcomes for each symptom at 4 weeks

Symptoms a No. (%) of reports based on the questionnaire b Overall Agreement Cohen's κ (95% CI)
Agreement Disagreement
Patient No / Physician No Patient Yes / Physician Yes Patient Yes / Physician No Patient No / Physician Yes
Fatigue 8 (6.3) 43 (33.9) 72 (56.7) 4 (3.2) 40.2% 0.01 (−0.07–0.09)
Pain 62 (48.8) 3 (2.4) 60 (47.2) 2 (1.6) 51.2% 0.02 (−0.05–0.09)
Sleep 60 (46.9) 1 (0.8) 66 (51.6) 1 (0.8) 47.7% −0.001 (−0.04–0.04)
Dyspnea 73 (57.5) 1 (0.8) 53 (41.7) 0 (0) 58.3% 0.02 (−0.02–0.06)
Constipation 60 (47.6) 21 (16.7) 40 (31.8) 5 (4.0) 64.3% 0.27 (0.13–0.41)
Appetite 63 (50.0) 29 (23.0) 25 (19.8) 9 (7.1) 73.0% 0.43 (0.27–0.58)
Nausea/Vomiting 78 (60.9) 20 (15.6) 16 (12.5) 14 (10.9) 76.5% 0.41 (0.24–0.59)
Diarrhea 72 (57.1) 21 (16.7) 31 (24.6) 2 (1.6) 73.8% 0.41 (0.26–0.56)
Symptoms No. (%) of reports based on the difference of scales c Overall Agreement Cohen's κ (95% CI)
Agreement Disagreement
Patient No / Physician No Patient Yes / Physician Yes Patient Yes / Physician No Patient No / Physician Yes
Fatigue 43 (34.1) 21 (16.7) 37 (29.4) 25 (19.8) 50.8% −0.006 (−0.18–0.17)
Pain 81 (63.8) 0 (0) 41 (32.3) 5 (3.9) 63.8% 0.03(−0.12–0.18)
Sleep 93 (73.2) 1 (0.8) 33 (26.0) 0 (0) 74.0% 0.04 (−0.04–0.12)
Dyspnea 96 (76.2) 0 (0) 30 (23.8) 0 (0) 76.2% 0.0 (NE)
Constipation 80 (63.5) 12 (9.5) 20 (15.9) 14 (11.1) 73.0% 0.241 (0.05–0.43)
Appetite 75 (60.0) 16 (12.8) 12 (9.6) 22 (17.6) 72.8% 0.31 (0.13–0.49)
Nausea/Vomiting 82 (64.6) 17 (13.4) 12 (9.5) 16 (12.6) 78.0% 0.40 (0.22–0.59)
Diarrhea 89 (70.6) 14 (11.1) 14 (11.1) 9 (7.1) 81.7% 0.44 (0.24–0.63)
Skin‐related toxicity 12 (10.4) 33 (28.7) 2 (1.7) 68 (59.1) 39.1% 0.06 (−0.01–0.14)

For skin‐related toxicity, the Dermatology Life Quality Index (DLQI) was used, which was defined as symptomatic if a change in DLQI score of at least four points.

Cohen's κ values: less than 0.00, poor agreement (gray); values between .00 and .20, slight agreement (gray); values between .21 and .40, fair agreement; values between .41 and .60, moderate agreement (bold).

Abbreviation: NE, not evaluable.

a

Physician‐reported outcome for each symptom was defined as positive if they had more than grade 1 according to the NCI‐CTC version 4.0.

b

Patient‐reported outcome for each symptom was defined as symptomatic if they answered “a little,” “quite a bit,” or “very much” to at least one of the symptom questions and asymptomatic if they answered “not at all” to all of the symptoms according to the EORTC QLQ‐C30.

c

Patient‐reported outcome for each symptom was defined as symptomatic if they had a difference of more than 10 points in change scores from baseline and asymptomatic if they had a difference of less than 10 points according to the EORTC QLQ‐C30.